Aehr Test Systems (NASDAQ:AEHR) Stake Boosted by Rhumbline Advisers

Rhumbline Advisers grew its stake in shares of Aehr Test Systems (NASDAQ:AEHR) by 3.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,333 shares of the semiconductor company’s stock after acquiring an additional 1,438 shares during the period. Rhumbline Advisers owned 0.14% of Aehr Test Systems worth $439,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. RiverPark Advisors LLC grew its holdings in shares of Aehr Test Systems by 360.8% during the 1st quarter. RiverPark Advisors LLC now owns 2,069 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 1,620 shares in the last quarter. nVerses Capital LLC purchased a new position in shares of Aehr Test Systems during the 2nd quarter valued at $25,000. B. Riley Wealth Advisors Inc. purchased a new position in shares of Aehr Test Systems during the 1st quarter valued at $109,000. Versor Investments LP purchased a new position in shares of Aehr Test Systems during the 2nd quarter valued at $117,000. Finally, ARS Investment Partners LLC purchased a new position in shares of Aehr Test Systems during the 2nd quarter valued at $131,000. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

Aehr Test Systems Trading Up 9.2 %

Shares of NASDAQ:AEHR opened at $13.13 on Friday. The stock has a market capitalization of $379.65 million, a PE ratio of 25.25 and a beta of 2.05. Aehr Test Systems has a 1 year low of $9.83 and a 1 year high of $48.28. The firm has a fifty day moving average price of $14.64 and a 200 day moving average price of $13.14.

Aehr Test Systems (NASDAQ:AEHR) last released its earnings results on Friday, July 19th. The semiconductor company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.70. The firm had revenue of $16.60 million during the quarter. Aehr Test Systems had a net margin of 50.07% and a return on equity of 36.41%. During the same period in the prior year, the firm earned $0.21 EPS. On average, sell-side analysts forecast that Aehr Test Systems will post 0.25 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on AEHR shares. StockNews.com cut shares of Aehr Test Systems from a “hold” rating to a “sell” rating in a report on Tuesday, August 27th. Craig Hallum upgraded shares of Aehr Test Systems from a “hold” rating to a “buy” rating and upped their price objective for the stock from $12.00 to $25.00 in a report on Wednesday, July 17th.

Insiders Place Their Bets

In other Aehr Test Systems news, Director Fariba Danesh sold 10,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $18.59, for a total transaction of $185,900.00. Following the completion of the transaction, the director now owns 16,390 shares of the company’s stock, valued at approximately $304,690.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Howard T. Slayen acquired 20,000 shares of the business’s stock in a transaction dated Friday, August 2nd. The stock was acquired at an average price of $15.50 per share, with a total value of $310,000.00. Following the completion of the transaction, the director now owns 220,714 shares of the company’s stock, valued at $3,421,067. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Fariba Danesh sold 10,000 shares of the company’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $18.59, for a total transaction of $185,900.00. Following the transaction, the director now directly owns 16,390 shares of the company’s stock, valued at approximately $304,690.10. The disclosure for this sale can be found here. Company insiders own 11.30% of the company’s stock.

Aehr Test Systems Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.